CTCFL and neoplasm: Moreover, recent study indicated that Brother of The Regulator of Imprinted Sites (BORIS, also known as CTCFL), a paralog of CTCF, is aberrantly upregulated in prostate, ovarian, lung and breast cancers (90–93) and its expression is correlated with tumour characteristics and therapeutic response (94).